Huntington's disease (HD) is a complex, inherited neurodegenerative disorder characterized by a progressive movement disorder, cognitive impairments, personality and psychiatric problems, as well as metabolic changes (Box 1) [1] . It is caused by an unstable expansion of a CAG sequence within the Huntingtin, known as HTT, gene which is located on chromosome 4 [2] . The protein encoded by the HTT gene is important in normal brain and neuronal development. The expanded CAG sequence leads to the production of an abnormal protein that causes brain cell dysfunction and ultimately neuronal cell death primarily in the basal ganglia but also the thalamus and cerebral cortex [3] . This single gene disease follows an autosomal, dominant inheritance affecting both men and women. Each offspring of an affected parent has a 50% chance of inheriting the gene mutation and developing the disease. Symptom onset usually occurs in mid age but a juvenile onset (<20 years of age) and late-age onset are also recognized. To some extent the age of onset is related to the size of the mutation [4] .
The prevalence of HD in Europe is estimated to be approximately four to ten individuals per 100,000. However, recent reports suggest that the number of individuals with HD is underestimated and that the true prevalence is considerably higher [5] .
HD is a family disease and most individuals have seen one of their parents of other family member go through the stages of the disease. This makes them very aware of what will or might happen to them in the future and has a significant influence on their knowledge of the disease and decision making, for example consenting to enteral tube feeding.
Stages of HD
There have been several attempts to define the stages of progression of HD and symptomatic stages are currently based upon the individuals total functional capacity score [6] . Current research may provide further clarification [7] . For these guidelines nutritional recommendations have been made in three stages of the disease; early, mid and late.
Early-stage disease cannot be defined as the time of diagnosis since diagnoses can be made at variable times. Most individuals present with early neurological features such as subtle changes in coordination and mild involuntary movements [3] . Psychiatric symptoms and cognitive changes often occur prior to the development of these motor signs. Hence in early stages depression, irritability and difficulty in planning, organizing and prioritizing activities can be experienced. Although maybe slightly less functional, people remain largely independent in their daily activities and lives [8] .
Mid-stage disease would be deemed to have been reached when the affected person has to cease work, or at least change employment to a post that is less challenging [8] . Involuntary movements increase and voluntary tasks will become more difficult. Executive dysfunction, including organizing, reasoned decision making, memory difficulties and reduced ability to learn new information make cognitive tasks more difficult [3] .
Late-stage disease occurs when employment becomes impossible, the individual is no longer able to live independently [8] , self-care ceases and cognitive decline is obvious. At this stage patients are severely limited in their mobility and are often chair or bed bound. Some patients maintain the ability to feed themselves to a late Weight loss is a common and recognized feature throughout all stages of the disease [9] [10] [11] and its etiology remains uncertain. Its progressive nature is often marked in the later stages [9, 12, 13] of the disease and correlates with the CAG repeat number [14] . Evidence, including animal studies, suggests that there are several possible contributing factors, such as:
Increased metabolic rate and higher energy expend iture perhaps seconda r y to hypothalamic dysfunction [10, 15] Possible peripheral abnormalities caused by the expression of the faulty protein in those tissues [12] Insufficient intake due to swallowing and feeding diff iculties [16] [17] [18] , including xerostomia [19] Hyperkinetic movement disorder [16] Possibly a combination of all the above points
There is great variation in the presence of symptoms and the impact of these on an individual's nutritional intake and status. Although within this standards of care (SoC) document, nutritional care has been subdivided into these three stages, according to the usual prevalence of the onset of the difficulty, it is important to note that individuals may experience the difficulties at any time of the disease progression.
Role of the European Huntington's Disease Network
The European Huntington's Disease Network (EHDN) provides a platform for clinicians and families to work together to find a cure for HD, to coordinate research and in the meantime to elicit best practice for the care of individuals with HD. Working groups were created to address the various themes [101] ; one group focusing on SoC with specialist subgroups. Care provision of HD varies widely between countries. The SoC working party has produced a consensus view for management of HD, which reflects the opinions of experts in their field, and will enable others to provide best care for the HD patient and their family.
The EHDN SoC Dietitians Group has brought together expert dietitians from across Europe to produce nutritional SoC to improve the nutritional management of individuals with HD. The information contained within this guidance is based on the available evidence in the nutritional care of individuals with HD, current nutritional support guidance and consensus of dietetic opinion within the field.
Aims of the nutritional guidelines
The aims of the Nutritional Management of Individuals with HD guidelines are to provide nutritional guidelines for dietitians to allow for optimal nutritional screening, assessment and management of individuals throughout all stages of HD, with the aim of improving the standard of nutritional care delivered and to ensure the nutritional management of individuals with HD is based on sound evidence and current best clinical practice.
Nutrition guideline development
The delivery of good nutritional care is a fundamental element of the management of individuals with HD. This guidance attempts to bring together the research evidence and expert dietetic opinion from across Europe in making nutritional recommendations for individuals with HD. However, it is important to acknowledge the differences in approaches between countries and professionals must also take account of their national legal requirements, national and local policies and procedures and professional codes of conduct in the interpretation of this guidance. Prior to the development of this guideline the literature was systematically searched in an attempt to ensure that the recommendations are based on sound evidence. However, a number of challenges were faced as the published literature in the field is limited, especially in terms of methods of nutritional screening and quantifying nutritional requirements in this patient group. The HD nutritional evidence base was difficult to interpret for clinical practice for the following reasons:
Few studies provided robust evidence for nutritional care in HD EBSCO Cinahl (1988 ) to evaluate evidence on BMI, weight loss, energy requirements and recommendations for nutritional support. A search strategy was developed in collaboration with the members of the SoC Dietitians Group. The literature search was updated during the development of the guideline. All relevant publications were identified and categorized to evidence statements according to SIGN methodology [102] . Due to the lack of scientific evidence, recommendations were primarily formulated based upon clinical experience and expert consensus from within the EHDN SoC Dietitians Group.
The importance of nutrition in HD Key nutritional priorities
Recommendations within published, generic, evidence-based nutritional guidelines [102, 103] are generally applicable in HD. However, due to the cognitive, motor, psychiatric and communication problems that occur in this progressive, degenerative condition additional nutritional factors need to be considered.
Unintended and sometimes rapid weight loss is common in people with HD and often occurs despite a good appetite [10, 20] and a high calorie intake [10] . Observation has shown that there can be variations in energy requirements throughout the course of the disease and between HD individuals [10, 11] but generally speaking, in the premanifest and early stages of HD, patients may already have higher energy requirements than the normal population [10, 20, 103] . This may explain why their BMI is often lower compared with the normal population. A higher bodyweight at diagnosis has been associated with a slower progression of the disease [21] . The cause of increased energy requirements and weight loss is not clear and most likely to be multifactorial.
However, due to the variability in energy requirements and the potential for rapid weight loss, early individual assessment and regular reviewing of nutritional care plans are vital. Therefore, the EHDN SoC Dietitians Group recommend that, on diagnosis, individuals with HD should receive the following dietetic care.
Ensuring adequate nutritional intake throughout each stage of the disease This will require adequate provision of suitable foods and fluids, either by the individual or their carers. Distinct nutritional challenges at each stage of the disease require careful dietetic management. Many individuals have very increased energy requirements and it is essentials to provide adequate macro-and micro-nutrients.
When weight loss occurs it can be very rapid therefore preventing weight loss and maintaining a healthy weight is very important. However, this can be difficult to achieve because the symptoms of HD also often have a profound effect on food intake.
Protective weight management
There is a high risk of rapid weight loss for many individuals but for some, rapid weight gain may occur. Studies have found that individuals with HD have a lower BMI than controls at diagnosis [14, 103] and younger age of onset usually denotes more aggressive disease and possibly an even lower BMI [21] . Rapid weight loss can result in loss of muscle mass, weakness, apathy, depression, susceptibility to infection and compromised chest status.
The risks may change during the progression of the condition but both unmanaged weight loss or weight gain will be problematic. For this reason weight should be carefully managed as standard weight management advice may be inappropriate for individuals with HD.
Nutrition & function
Poor nutrition is known to impact on function in certain neurological populations, for example, elderly stroke patients [22, 23] . Although there are no studies looking at nutrition and function in HD per se, due to the physical and cognition difficulties poor nutrition has a much greater impact on this group. The affected functions include strength and muscle mass, levels of fatigue (already low in this population group) mood (which can already be compromised by www.futuremedicine.com 37 the disease itself ) and cognitive function. It therefore seems reasonable to ensure optimal nutrition so that these factors are not further exacerbated by poor diet.
Physical impact on nutritional intake
The main physical problems are difficulties with motor coordination and muscle control, which may result in uncontrolled movements and diff iculty walking, speaking and swallowing. Uncoordinated movements are a challenge when handling cutlery and taking food to the mouth. Chewing and swallowing difficulties arise from uncoordinated movement of the face, neck, lips and diaphragm. This can make eating and drinking a tiring experience. Other common problems are vomiting, reflux and regurgitation of food as the systems for moving food through the digestive system become disrupted.
Cognitive changes affecting food intake
Cognitive changes related to the ability to think, impact on problem solving, planning and sequencing of ideas. This includes the decisions before the food enters the mouth and may lead to an inappropriate food choice and/or eating too much too quickly. Concentration and memory can also be affected. Overall, an individual's awareness and ability to make judgments becomes more impaired.
Nutrition & emotion
Mood swings and changes in emotional responses are common, all of which can adversely affect behaviour. Depression can occur and affect the person's appetite and anxiety is common. Anxiety can make movements more pronounced and affect the swallowing process. Frustration may occur when faced with being unable to prepare food and eat in the usual way. Many people with HD have a great resistance to adaptive changes to their lifestyle, which can make accepting advice for safer eating or altering the texture of food and fluid difficult.
Nutrition & oral health
Particular attention should be given to oral health especially where dietary advice increases the intake of simple carbohydrates and/ or frequency of meals and snacks as dental decay can result. Due to their facial and body movements, they are a very difficult group for dentists to treat. Oral health will impact on the risk of chest infections from aspiration of bacteria-laden saliva and will also impact the ability to eat and drink if the patient has dental problems or pain.
Multidisciplinary approach
Healthcare professionals should ensure that all people who need nutrition support receive coordinated care from a multidisciplinary team (MDT) [103] . It is recognized that members of the MDT will vary depending upon the setting and local policy, but we stress the importance of management of specific difficulties by trained therapists, for instance, management of swallowing difficulties by appropriately trained speech and language therapists. Ideally, the team will also include those who have specialist skills in positioning and aides for feeding. HD is a neurological condition of long duration and as such may have a lengthy palliative phase. Diagnosis of HD will have a major impact on the quality of life (QoL) of the affected individual and their family [24] . A multidisciplinary approach is vital to ameliorate the problems encountered in caring for this population [25] .
Behavioral aspects of the disease present major nutritional challenges
The disease presents a range of behavioral issues as a consequence of psychological and cognitive deterioration that can impact on nutritional intake. There may be an inability to express food preferences or to inform carers of discomfort when eating, leading to frustration that can present as challenging behavior. This can be especially apparent at mealtimes and requires skilled feeding techniques and careful management by carers. Obsessive behaviors, often seen in HD, can impact on food choices and dealing with these issues can be very challenging.
Respecting autonomy
Individuals with HD often lack insight into their own disease progression. They may not be aware of, or are not able to, acknowledge progressive symptoms. Individuals will often refuse advice and interventions because of a decline in cognitive ability, and especially in executive function. All nutritional advice provided should be set within the context of QoL and patient choice.
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Nutritional assessment & evaluation Nutritional screening tools
All patients with HD will at some time need dietary intervention because of the sequela of the disease. On diagnosis they should be screened for malnutrition and risk of malnutrition by a trained healthcare professional using a validated screening tool. Suitable tools include the Malnutrition Universal Screening Tool (MUST) [26] , Mini Nutritional Assessment [27] and the Short Nutritional Assessment Questionnaire [28] . Screening should be repeated according to clinical need and local policy as specified in the screening tool adopted. It must be stressed that individuals with HD who are not underweight, and therefore not identified as 'at risk' on screening, may have an inadequate intake of energy and nutrients because of factors such as poor food choices or excessive alcohol intakes; therefore it is important that a diet history is taken regardless of the MUST score/screening outcome.
Nutritional assessment & evaluation
The EHDN Dietitians Group suggest the following recommendations for the nutritional management of individuals with HD, based on a consensus of dietetic expert opinion. NICE [103] and ESPEN [102] guidance should be used as a guide where appropriate but additional issues need to be considered.
Nutritional support should be considered in those who are malnourished, as defined by any of the following:
Unintentional weight loss greater than 10% within the last 3-6 months A BMI of less than 20 kg/m 2 and unintentional weight loss greater than 5% within the last 3-6 months [103] 
5
Discuss tube feeding within MDT and identify a member of the team to discuss it with the patient focusing on potential benefits and burdens. Record the individual's wishes Discussing tube feeding in the early stages of the disease before cognitive function diminishes and communication becomes difficult. Many individuals have witnessed family members experience similar issues and are aware of the impact of the advancing disease Discussions must be patient led; some patients will want to discuss feeding fully but others will want to avoid or defer decision making. Group discussions or education facilitated by the dietitian may be beneficial www.futuremedicine.com
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A BMI of less than 20 kg/m 2 (expert opinion is to aim to maintain BMI [23] [24] [25] Nutritional support should also be considered for those individuals who struggle to maintain their bodyweight and those at risk of malnutrition, defined as individuals who have:
A: Eaten little or nothing for more than 5 days and/or are likely to eat little or nothing for 5 days or longer B: Food intake below 50-75% in preceding week C: A poor absorptive capacity and/or high nutrient losses and/or increased nutritional needs from causes such as catabolism Expert dietetic opinion is also that weight loss should be considered in individuals with either BMI of 27-30 with comorbidities or for those with a BMI of over 30 without comorbidities. Individuals should only be advised to lose weight under the supervision of a dietitian. They will require review every 2-4 weeks because of the risks of rapid weight loss in some patients.
Optimizing nutritional intake in the different stages of HD Nutritional management of individuals with HD
The nutritional assessment and nutritional care planning process should ensure that the total nutrient intake of individuals with HD provides sufficient energy, protein, fluid, electrolyte, mineral, micronutrients and fiber needs [103] . The assessment must take account of the possible increased nutritional needs, especially kilocalorie requirements that can, in some individuals, be very high.
Gaba [29] recommended HD specific equations for the calculation of energy although there is a lack of HD-specific calculations for protein and fluid requirements. Nutritional requirements can be calculated using a standard equation (such as Schofield, Harris Benedict) and the individual's current kilocalorie intake and weight history should form an integral part of the baseline nutritional assessment to determine estimated requirements.
Frequent monitoring of nutritional intake, weight and weight changes is required and adjustments to nutritional intake will need to be made to achieve the identified nutritional goals. As a baseline for calculating requirements, the following NICE guidance [103] is appropriate but Dietitians must be aware that some individuals will have much higher kilocalorie requirements and other nutritional needs. The EHDN Dietitians Group make the following HD-specific recommendations, incorporating NICE guidance:
25 (Table 2 ) and end-stage disease (Table 3) . Table 4 outlines the issues to be considered in the decision-making process for enteral tube feeding.
Conclusion
Nutritional screening and the delivery of good nutritional care are fundamental elements of It should be noted that although the guidance has been written specifically for patients with HD, much of the information may also be valuable across other neurodegenerative diseases. The EHDN SoC Group plan to audit compliance to these SoC across the network and are planning a quality improvement program to support units to deliver against these standards.
Future perspective
Improving the nutritional care of individuals with HD is likely to become much more of a priority focus for healthcare systems globally. Parenteral and enteral nutrition societies and associations are lobbying governments and health departments to ensure that nutritional care is given the priority focus that it deserves. There is an urgent need for further research into the nutritional care of patients with HD as the role of nutrition in the treatment of the disease remains poorly understood. Table 4 . Decision making for enteral tube feeding.
Recommended level of nutritional care
Rationale for the recommendation 1 If the person has an advanced directive stating they do not want a feeding tube, this is always upheld This is legally binding in many European countries 2 Discuss the benefits and burdens of enteral feeding as early as possible and record the patient's wishes, family members should be involved in these discussions where appropriate If the person has capacity to decide whether or not they would want a feeding tube, then they should be educated to make an informed choice Everything that is necessary to facilitate an individual's understanding and retention of the information should be tried. If capacity is uncertain than an assessment of capacity should be carried out Ideally this should not be done at a time of crisis. These discussions should take place prior to the need for enteral feeding arising
Family members should to be included in discussions (where appropriate) as they will often be supporting the patient Consent is required for patients able to make decisions about their care for any medical procedure/treatment Patients do change their minds so it is good practice to routinely ask at intervals if their decision still stands These expressed wishes and views count as verbal advance directives and should always be documented for future reference (i.e., when the patient may no longer be able to communicate) 3
If the patient lacks capacity a multidisciplinary discussion is essential and local and national policy must be followed
It is not possible to make a Europe-wide recommendation given the differences in legal and clinical systems 4
The following should be considered to ensure a best interest decision is made: Any previous expressed views on polyethylene glycols Verbal directives to family members/carers Family views on whether they would want this Perceived quality of life; this is very subjective Swallowing difficulty, fear of choking, infection history, weight change and level of distress eating causes Benefit or burden of feeding
In making a best interest decision it is important to look at the current situation for the person as it is It is also relevant to know how they were as a person and what they would likely do in this situation if they were able to make a decision This is where it is important to consult staff and family that may have had input with the person when they expressed such views
Production of the guidelines
This guideline has been developed by the EHDN SoC Dietitians Group, a group of collaborating dietitians, nutritional specialists and healthcare professionals from across Europe. The group is chaired by Sheila Simpson and Daniela Rae.
